Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Attention-deficit hyperactivity disorder management Stories

2009-07-22 17:15:00

Vyvanse first oral ADHD stimulant with published data demonstrating significant ADHD symptom improvement from 1.5 hours up to 13 hours after administration in childrenShire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse® (lisdexamfetamine dimesylate) CII significantly reduced the symptoms of...

2009-07-22 08:00:00

PHILADELPHIA, July 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse(R)( )(lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 from the first time point measured (1.5 hours) up to the...

2009-07-08 17:00:00

Consumers Could Save Roughly $3,000 A Year By Switching From Expensive Brand Name Drugs to Equally Effective Generics To Treat Attention Deficit Hyperactivity Disorder (ADHD) YONKERS, N.Y., July 8 /PRNewswire-USNewswire/ -- According to a new Consumer Reports Best Buy Drugs report, parents should be skeptical if their doctors offer them free prescription drug samples, especially for the treatment of attention deficit hyperactivity disorder (ADHD). Free samples can hook consumers on...

2009-07-01 11:05:35

 Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 3b study that found VYVANSE® (lisdexamfetamine dimesylate) CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment study in adults with Attention Deficit Hyperactivity Disorder (ADHD). VYVANSE is the first approved stimulant for adults with ADHD to be evaluated in this setting, and these data...

2009-07-01 08:00:00

VYVANSE is the first stimulant to establish duration of efficacy from two hours up to 14 hours after administration in adults with ADHD HOLLYWOOD, Fla., July 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 3b study that found VYVANSE(R) (lisdexamfetamine dimesylate) CII demonstrated significant efficacy at 14 hours after administration during a simulated workplace environment study in adults...

2009-06-29 23:57:31

U.S. researchers find a placebo effect, not in children taking the medication for attention deficit-hyperactive disorder, but in the adults in their lives. The review of existing studies evaluating whether placebos produce significant changes in children with ADHD -- published in the Journal of Development & Behavioral Pediatrics -- suggests teachers, parents and other adults tend to view and treat more favorably children who they think are receiving medication, whether or not medication...

0d39cf1dae95bad33b4076507742bf311
2009-06-16 06:00:00

New evidence from a government-backed study suggests that attention deficit drugs like Ritalin and Adderall can increase the risk of sudden death, yet federal health regulators continue to urge parents to keep their children on the medications. The study, which appears in the American Journal of Psychiatry, suggests that the stimulant drugs used to treat attention deficit and hyperactivity disorder may be linked to sudden death in children and adolescents. Drugs like Ritalin and Adderall...

2009-06-01 08:00:00

ADHD symptom control demonstrated from the first time point measured (1.5 hours) through 13 hours postdose PHILADELPHIA, June 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment VYVANSE(R) (lisdexamfetamine dimesylate) CII, to include...

2009-05-27 09:17:00

More than five million Americans currently take medication to manage their symptoms of attention deficit disorder. Yet untold millions remain undiagnosed and untreated for ADHD - partially because the process can be so daunting. A new downloadable eBook from ADDitude magazine aims to simplify things with expert explanations of popular ADD medications, potential side effects, non-drug alternatives, and more. NEW YORK, May 27 /PRNewswire/ -- ADDitude magazine, the leading publication for...

2009-05-25 11:30:54

Children with attention-deficit hyperactivity disorder can actually concentrate better if allowed to fidget, a University of Central Florida study says. A team of researchers at the Orlando university said by studying 23 preteen male subjects, 12 of whom had been diagnosed with ADHD, they found the ADHD subjects began to noticeably fidget when facing short-term memory problems, the Orlando (Fla.) Sentinel said Monday. Dr. Mark Rapport, who led the study, said fidgeting allows ADHD sufferers...